Schedule
2010 NIH Seminar Series: Advances in Public Health Genomics
In 2007, the NCI organized a highly successful monthly seminar series entitled: “Public Health Genomics: Closing the Gap between gene discoveries and population health” Over 9 months, 18 lectures by various expert speakers explored the topic of public health genomics, with a focus on cancer control and prevention. The lectures power point slides, reading materials and webcasts are all archived on the NCI website. The 2008-2009 series “advances in public health genomic explored ongoing, planned and future initiatives led by the NIH and other groups designed to accelerate the process for integrating advances in genomics and related fields into practice.
There is a continued need for raising awareness, developing competencies and generating ideas for initiatives that can integrate genomics into population sciences to assess the role of genomics in practice and prevention. In addition, there are major ongoing genomics initiatives at NCI, other Institutes as well as cross cutting NIH road map initiatives related to genomics. All these initiatives will lead to new knowledge and gene discoveries that could have lasting impact on healthcare and population health.
Nevertheless, the emerging scientific translation needs in the genomics era are substantial. Population sciences are now urgently needed to assess the distribution of genetic variants and their products biomarkers, and interactions with other genes and environmental factors. New methods are needed to assess the contribution of genes and gene-environment interactions (behavior, nutrition, chemicals, and other exposures) to individual and population risks for various cancers and other common diseases. Behavioral and social sciences are needed to assess how genetic information can be used to effect behavior change to reduce the burden of cancer and other diseases. As importantly, delivery research on clinical utility, effectiveness, and economics of genomics-based health care applications are needed to assess their added value in disease care and prevention. Genomics and related fields will also affect surveillance, dissemination and diffusion research as well as evaluation of disease progression and survivorship. Without the expansion of population sciences in genomics, the promise of genome research and discoveries may not reach its full potential.
The 2010 series will feature examples of discovery to action including case studies across disease categories to illustrate public health genomics interdisciplinary principles as they apply to diseases of public health significance.
Session 1: Genomics and human disease: The case of missing heritability
Teri Manolio, MD, PhD (NHGRI)
Wednesday, February 3, 2010- 1:00-2:00 EPN H
Session 2: Using genomics in risk assessment and prevention of coronary heart disease
Chris O’Donnell, MD (NHLBI)
Wednesday, Feb 24, 2010- 1:00-2:00 EPN C-F
Session 3: Three billion base pairs on a chip: so what do we do with our personal genome?
Les Biesecker, MD (NHGRI)
Wednesday, March 17, 2010- 1:00-2:00 EPN H
Session 4: Current initiatives in translating human genome discoveries into population health benefits
Muin J. Khoury, MD, PhD (CDC; NCI-DCCPS)-The genomic applications in practice and
prevention network
Sharon Terry, MS (The Genetic Alliance)- The genetics for early disease detection and
intervention initiative
Wednesday, April 7, 2010- 1:00-2:00 EPN C-F
Session 5: What are the implications of gene-environment interactions in lung cancer and smoking addiction for prevention and contro?l
Neil Caporaso, MD (NCI): Epidemiologic perspectives
Stephen Marcus, PhD (NCI): Control and prevention perspectives
Wednesday May 5, 2010-1:00-2:00 EPN C-F
|
